Relief Therapeutics Holding and APR Applied Pharma Research have signed a binding term sheet for relief to acquire all outstanding shares of APR. According to the Term Sheet, the APR shareholders will receive from Relief
Tags :Ex-Featured
NKF acted with team led by corporate partner Patrik Peyer (pictured) working with associate Alexander Göbel (Corporate).
On 18 August 2020, Valaris (one of the largest oil rig owning companies in the world) filed for bankruptcy in the Southern District of Texas with over USD 7 billion of financial debt. Walder Wyss advised with respect
Lenz & Staehelin advised Swissquote on the creation of Yuh, its digital banking joint venture with PostFinance, advised by Walder Wyss. “Yuh” is a new Swiss digital banking application, which makes it possible to carry
Nestlé will acquire, from the US-based global investment firm KKR, core brands of The Bountiful Company for 5.75 billion usd. The transaction includes the high-growth brands Nature’s Bounty, Solgar, Osteo Bi- Flex and Puritan’s
Bank J. Safra Sarasin Group acquired Bank of Montreal’s (BMO) Private Banking Business in Hong Kong and Singapore. Walder Wyss advised Bank J. Safra Sarasin as lead counsel on the transaction and on the
Walder Wyss advised on Relio’s pre-Seed round. Relio is a startup developing the first Swiss digital bank account specifically for SMEs with a technology platform which will allow compliance to be largely automated. It
ISS, a global leading facility services provider, has agreed to sell its Swiss subsidiary ISS Kanal Services AG to the London based private equity firm KLAR Partners. ISS Kanal Services AG is a leading Swiss
Walder Wyss advised the buyer of a majority stake in Fedafin AG, a FINMA recognized rating agency with a broad market base and a provider of issuer and issue ratings for Swiss companies and municipalities.
PolyPeptide Group AG, a global operator in peptide development and manufacturing, successfully priced its initial public offering (IPO) at CHF 64 per share, implying a market capitalization of CHF 2.12 bn. The base offering of the IPO
